about
Neonatal exposure to estradiol/bisphenol A alters promoter methylation and expression of Nsbp1 and Hpcal1 genes and transcriptional programs of Dnmt3a/b and Mbd2/4 in the rat prostate gland throughout lifeUterine signaling at the emergence of the embryo from obligate diapause.High mobility group nucleosomal binding domain 2 (HMGN2) SUMOylation by the SUMO E3 ligase PIAS1 decreases the binding affinity to nucleosome core particles.HMGN2, a new anti-tumor effector molecule of CD8⁺ T cells.An integrated expression profiling reveals target genes of TGF-β and TNF-α possibly mediated by microRNAs in lung cancer cellsHMGB1 in health and disease.Nuclear GIT2 is an ATM substrate and promotes DNA repairThe HMGN family of chromatin-binding proteins: dynamic modulators of epigenetic processes.Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterationsRelationship between XRCC1 and XPD polymorphisms and the risk of the development of hepatocellular carcinoma: A case-control study.Nucleosome-binding protein HMGN2 exhibits antitumor activity in oral squamous cell carcinoma.Loss of the nucleosome-binding protein HMGN1 affects the rate of N-nitrosodiethylamine-induced hepatocarcinogenesis in mice.Nuclear morphometry, nucleomics and prostate cancer progressionThe high mobility group box: the ultimate utility player of a cell.The role of the nucleosome acidic patch in modulating higher order chromatin structure.Elevated HMGN4 expression potentiates thyroid tumorigenesis.Knockdown of HMGN5 suppresses the viability and invasion of human urothelial bladder cancer 5637 cells in vitro and in vivo.HMGN5 knockdown sensitizes prostate cancer cells to ionizing radiation.Knockdown of HMGN5 increases the chemosensitivity of human urothelial bladder cancer cells to cisplatin by targeting PI3K/Akt signaling.Profiling DNA damage and repair capacity in sea urchin larvae and coelomocytes exposed to genotoxicants.Increased expression of high-mobility group nucleosomal-binding domain 2 protein in various tumor cell lines.Abnormal expression of is significantly associated with malignant transformation of hepatocytes
P2860
Q28567904-FC2BAEF5-B6BD-4DED-AFBA-82BE86EE2A29Q33815064-7795D524-8592-459A-8737-451BB31A592DQ33931136-BB5FEB6D-F6A0-478B-A1BB-2CFC76ACC18DQ34020224-CE816D28-4C0D-479B-8B23-A9575BDE649FQ34599038-67D5C20B-75C3-49A6-9B3E-50DEF86B1185Q34622835-1D8B96C0-AF32-4D59-9C07-360A11C65FBBQ35165183-A0991F65-05ED-47F6-92C4-ED414B0780E9Q36019835-3080784C-CE71-4BEF-85B9-F6CBC4875D16Q36127123-0FDE0363-7D14-4426-B37C-BD17F4D90031Q36226099-B93D77D5-6D7A-4E28-8B18-5BE783A47908Q37388656-3FB80A31-B78D-4695-9985-3DB1AC888E5FQ37529082-39C0147E-5E32-4552-BC37-51ACB76C229EQ38002780-A6A4ED8B-1363-4F8F-AD50-316767584AEFQ38060015-05F1EF7C-643F-4142-80B0-5919496EFCB4Q38085143-ED49519A-1772-4FAB-8E01-831049D92FC0Q38716948-6D67A142-C55E-4174-B354-1DE655C09981Q38896739-B1C7F801-5B7E-4CFE-84FE-B386D513BEC4Q38948744-1CB2E3A4-6765-46FF-98F5-6B0E9070B1A0Q45792633-E3A28529-6A86-4DFF-A82F-2ABC44C8BD72Q50954794-2E479217-40AF-42EB-BB9E-78D36572DDBBQ55261076-11F99F87-0FF4-48BF-9015-05572FBF4123Q58699259-3E70BAE7-17A2-40DD-9235-67242FFA4E16
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
HMGNs, DNA repair and cancer.
@ast
HMGNs, DNA repair and cancer.
@en
type
label
HMGNs, DNA repair and cancer.
@ast
HMGNs, DNA repair and cancer.
@en
prefLabel
HMGNs, DNA repair and cancer.
@ast
HMGNs, DNA repair and cancer.
@en
P2860
P1476
HMGNs, DNA repair and cancer.
@en
P2860
P356
10.1016/J.BBAGRM.2009.10.007
P407
P50
P577
2009-12-08T00:00:00Z